Literature DB >> 15139528

In vivo phage display to identify M cell-targeting ligands.

Lisa M Higgins1, Imelda Lambkin, Graham Donnelly, Daragh Byrne, Carolyn Wilson, Jacqueline Dee, Melanie Smith, Daniel J O'Mahony.   

Abstract

PURPOSE: The purpose of this study was to use in vivo phage display screening technology to identify novel lead peptides that target delivery to M cells and to follicle-associated epithelium (FAE) of the intestine.
METHODS: Phage display libraries were screened in vivo within the gastrointestinal tract of a rat model by successive screenings across four cycles of selection.
RESULTS: Following four cycles of in vivo screening, we identified 30 unique peptide sequences that bound to Peyer's patch tissue, human Caco-2, and rat IEC-6 epithelial cells. Two of the lead targeting peptides, peptides P8 (LETTCASLCYPS) and P25 (VPPHPMTYSCQY), were shown to bind to receptors on the surface of human intestinal tissue. The L-form, D-form, retro-inverted D-form, and selective Cys-to-Ala site-directed mutants of peptides P8 and P25 were also shown to retain binding to Caco-2 cell membranes when immobilized on the surface of a model particulate. Finally, the D-peptide analog of peptide P8 (yqcsytmphppv) enhanced the delivery of polystyrene particles to M cells in vivo in a mouse model, and these particles were delivered into Peyer's patch tissue, as determined by confocal microscopy.
CONCLUSIONS: In summary, we have identified novel ligands that target M cells and Peyer's patch tissue, and thus may have utility in the targeted oral delivery of vaccines and vaccine carrier systems to the mucosal immune system within the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139528     DOI: 10.1023/b:pham.0000022418.80506.9a

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  44 in total

1.  Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.

Authors:  M A Conway; L Madrigal-Estebas; S McClean; D J Brayden; K H Mills
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

2.  Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs).

Authors:  R Glück
Journal:  Vaccine       Date:  1999-03-26       Impact factor: 3.641

Review 3.  New approaches to the development of live attenuated rabies vaccines.

Authors:  Bernhard Dietzschold; Matthias J Schnell
Journal:  Hybrid Hybridomics       Date:  2002-04

4.  Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

Authors:  C O Tacket; J Galen; M B Sztein; G Losonsky; T L Wyant; J Nataro; S S Wasserman; R Edelman; S Chatfield; G Dougan; M M Levine
Journal:  Clin Immunol       Date:  2000-11       Impact factor: 3.969

5.  Steps toward mapping the human vasculature by phage display.

Authors:  Wadih Arap; Mikhail G Kolonin; Martin Trepel; Johanna Lahdenranta; Marina Cardó-Vila; Ricardo J Giordano; Paul J Mintz; Peter U Ardelt; Virginia J Yao; Claudia I Vidal; Limor Chen; Anne Flamm; Heli Valtanen; Lisa M Weavind; Marshall E Hicks; Raphael E Pollock; Gregory H Botz; Corazon D Bucana; Erkki Koivunen; Dolores Cahill; Patricia Troncoso; Keith A Baggerly; Rebecca D Pentz; Kim-Anh Do; Christopher J Logothetis; Renata Pasqualini
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

6.  M cell-targeted DNA vaccination.

Authors:  Y Wu; X Wang; K L Csencsits; A Haddad; N Walters; D W Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

7.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Authors:  W Arap; R Pasqualini; E Ruoslahti
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

Review 8.  Microparticle vaccine approaches to stimulate mucosal immunisation.

Authors:  D J Brayden; A W Baird
Journal:  Microbes Infect       Date:  2001-08       Impact factor: 2.700

9.  Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

Authors:  M Conacher; J Alexander; J M Brewer
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

10.  Human intestinal M cells display the sialyl Lewis A antigen.

Authors:  P J Giannasca; K T Giannasca; A M Leichtner; M R Neutra
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  13 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

2.  Ligand-directed profiling of organelles with internalizing phage libraries.

Authors:  Andrey S Dobroff; Roberto Rangel; Liliana Guzman-Roja; Carolina C Salmeron; Juri G Gelovani; Richard L Sidman; Cristian G Bologa; Tudor I Oprea; C Jeffrey Brinker; Renata Pasqualini; Wadih Arap
Journal:  Curr Protoc Protein Sci       Date:  2015-02-02

Review 3.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

Review 4.  M cell-targeted mucosal vaccine strategies.

Authors:  M Yamamoto; D W Pascual; H Kiyono
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 5.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

6.  An in vivo selection-derived d-peptide for engineering erythrocyte-binding antigens that promote immune tolerance.

Authors:  Alexander R Loftis; Genwei Zhang; Coralie Backlund; Anthony J Quartararo; Novalia Pishesha; Cameron C Hanna; Carly K Schissel; Daniel Garafola; Andrei Loas; R John Collier; Hidde Ploegh; Darrell J Irvine; Bradley L Pentelute
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-24       Impact factor: 11.205

7.  Targeting mammalian organelles with internalizing phage (iPhage) libraries.

Authors:  Roberto Rangel; Andrey S Dobroff; Liliana Guzman-Rojas; Carolina C Salmeron; Juri G Gelovani; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Nat Protoc       Date:  2013-09-12       Impact factor: 13.491

8.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

Review 9.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Ecological basis for rational phage therapy.

Authors:  A V Letarov; A K Golomidova; K K Tarasyan
Journal:  Acta Naturae       Date:  2010-04       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.